Cell Culture Market worth 18.63 Bn USD by 2020

Friday 26 February 2016, Amsterdam

$ The report, now available on ASDReports, "Cell Culture Market by Equipment (Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)), Consumables (FBS, ABS, Media, Reagents), Application (Therapeutics, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) - Forecast to 2020", The global cell culture market is expected to reach USD 18,630.7 Million by 2020 from USD 11,310.9 Million in 2015, at a CAGR of 10.5% during the forecast period.

Cell Culture Market, by Equipment [Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)], Consumables (FBS, ABS, Media, Reagents), Application (Therapeutic, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) - Forecast to 2020 analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

The report segments the cell culture market based on product, application, end user, and region. On the basis of products, the cell culture market is segmented into instruments and consumables. The instruments market is further segmented into bioreactors, cell culture vessels, cell culture storage equipment, and cell culture supporting instruments. The consumables market is further categorized into sera, media, and reagents; and bioreactor accessories. The consumables segment is expected to account for the largest share of the cell culture market in 2015.

Factors such as the increasing incidence of chronic diseases, increasing regulatory approvals for cell culture-based vaccines, increasing demand for mAbs, funding for cell-based research, growing use of single-use technologies, and technological advancements in cell culture products are driving the growth of the cell culture market during the forecast period.

Among end users, the pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR during the forecast period. On the basis of region, the cell culture market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of this market in 2015. However, the Asian market is expected to grow at the highest CAGR, mainly due to favorable regulatory guidelines, government support for cell culture-based vaccine production, low manufacturing costs, and the growing focus of global market players on emerging Asian economies.

The cell culture market is highly competitive, encompassing a range of major as well as emerging players. Key market players Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.K.), Merck KGaA (Germany), Sartorius AG (Germany), Eppendorf AG (Germany), Lonza AG (Switzerland), Corning, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Promocell GmbH (Germany), and Hi-Media Laboratories (India).